Response Genetics Inc.

response genetics inc. - All News and Analysis

• Response Genetics, Inc. Appoints John Ferrara to Its Board of Directors

  - 2008-04-10

  LOS ANGELES -- Response Genetics, Inc. (NASDAQ: RGDX), a company focused on the development of molecular diagnostic tests for cancer, announced today that John C. Ferrara has joined its Board of Directors. Mr. Ferrara is currently the Chief Financial Officer CFO for EDGAR[R] Online[R], Inc. (NASDAQ: EDGR) a leading...

  Tags: board, Company, Mr., Nasdaq Stock Market Inc., Response Genetics Inc.

• Response Genetics, Inc. Update Call Transcript

  Seeking Alpha - 2008-03-26

  Question-and-Answer SessionOperator Thank you. We will now be conducting a question and answer session. Operator Instructions One moment please, while we pull for questions. Our first question comes from Zarak Khurshid with Caris & Company. Please proceed with your questions. Zarak Khurshid-Caris & Company Thanks. Hi Kathy and Tom,...

  Tags: Response Genetics Inc.

Additional Resources

• Response Genetics, Inc. Reports Third Quarter and Year-to-Date 2008 Financial Results

  - 2008-11-07

  LOS ANGELES -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and commercialization of molecular diagnostic tests for cancer, today announced its consolidated financial results for the three and nine months ended September 30, 2008. "This quarter, we are very pleased with the commercial introduction of...

• NeoGenomics Announces Results for the Third Quarter of Fiscal Year 2008

  - 2008-11-06

  62% year-over-year increase in revenue; Substantial improvement in liquidity FT. MYERS, Fla., Nov. 6 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (BULLETIN BOARD: NGNM) today announced its results for the third quarter of FY 2008. Significant accomplishments during the quarter included the following: Third Quarter...

• Response Genetics, Inc. to Release Third Quarter 2008 Financial Results and Present at the Rodman & Renshaw Tenth Annual Healthcare Conference

  - 2008-11-05

  LOS ANGELES -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests for cancer, will announce third quarter 2008 financial results Friday, November 7 after close of market. Response Genetics also announced that its president and CEO, Kathleen Danenberg, will present...

• Response Genetics, Inc. to Present at the Maxim Group Growth Conference

  - 2008-10-02

  LOS ANGELES -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sales of molecular diagnostic tests for cancer, today announced that its management will present at the Maxim Group Growth Conference in New York on Oct. 7. The conference will be held at the Grand Hyatt New...

• Response Genetics Launches National Sales Strategy for Its ResponseDX™ Tests Through Exclusive Agreement With NeoGenomics Laboratories and Formation of Sales Team

  - 2008-09-29

  LOS ANGELES -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests for cancer, announced today an agreement with NeoGenomics Laboratories, a clinical laboratory service provider of oncology focused genetic diagnostic tests, and the formation of its own sales team, as part of...

• Response Genetics Reports Second Quarter 2008 Financial Results and Highlights

  - 2008-08-12

  LOS ANGELES -- Response Genetics, Inc. (NASDAQ: RGDX), a company focused on the development of molecular diagnostic tests for cancer, today announced its consolidated financial results for the second quarter of 2008, and six months ended June 30, 2008. Second Quarter 2008 Results Total revenue increased...

• Response Genetics, Inc. to Release Second Quarter 2008 Financial Results

  - 2008-08-07

  LOS ANGELES -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and commercialization of molecular diagnostic tests for cancer, will announce second quarter 2008 financial results Tuesday, August 12 after close of market. About Response Genetics, Inc. Response Genetics, Inc. ("RGI"; the "Company") (Nasdaq:...

• Wall Street Media Presents Exclusive Videos from the Collins Stewart Conference and the T. Boone Pickens Press Conference

  - 2008-07-09

  NEW YORK -- Wall Street Media is presenting an exclusive highlight video from the presentation of Ms. Kathleen Danenberg, President and CEO of Response Genetics, Inc., (NASDAQ: RGDX), at the Collins Stewart Fourth Annual Growth Conference, held on July 8-10, 2008 at the Mandarin Oriental Hotel in New York City....

• Response Genetics, Inc. to Present at the Collins Stewart Fourth Annual Growth Conference

  - 2008-07-08

  LOS ANGELES -- Response Genetics, Inc. (NASDAQ:RGDX) today announced that its president and CEO, Kathleen Danenberg, will provide a business overview, including an update on its ResponseDXTM PCR-based genetic tests, at the Collins Stewart Fourth Annual Growth Conference at the Mandarin Oriental Hotel in New York City on July 8-10....

• Response Genetics, Inc. to Hold Annual Meeting of Shareholders Tuesday, June 17, 2008 at 1:00 pm EDT

  - 2008-06-16

  LOS ANGELES -- Response Genetics, Inc. (NASDAQ:RGDX) today announced that it will hold its Annual Meeting of stockholders on Tuesday, June 17, 2008, beginning at 1 p.m. EDT. The items for consideration at the meeting are included in the Proxy Statement, which has been mailed to shareholders of...

• Response Genetics, Inc. Reports First Quarter 2008 Financial Results

  - 2008-05-15

  LOS ANGELES -- Response Genetics, Inc. (NASDAQ: RGDX), a company focused on the development and commercialization of molecular diagnostic tests for cancer, today announced its consolidated financial results for the three months ended March 31, 2008. "These results, coupled with our expansion of the ResponseDX: Lung[TM] and ResponseDX:...

• Response Genetics, Inc. to Release First Quarter 2008 Financial Results and Present at the Rodman & Renshaw Fifth Annual Global Healthcare Conference

  - 2008-05-13

  LOS ANGELES -- Response Genetics, Inc. (NASDAQ: RGDX) will announce first quarter 2008 financial results in a press release Thursday, May 15 after close of market. Response Genetics, Inc. also announced today that Kathleen Danenberg, President and CEO of Response Genetics, Inc., will present at the Rodman &...

• Response Genetics, Inc. Announces the Appointment of David Gandara, M.D. to Its Board of Directors

  - 2008-05-08

  Dr. Gandara is a Well-Known Expert in Lung Cancer and Developmental Therapeutics LOS ANGELES -- Response Genetics, Inc. (NASDAQ: RGDX), a company focused on the development of molecular diagnostic tests for cancer, announced today the appointment of David Gandara, M.D. to its Board of Directors. Dr. Gandara, a...

• Response Genetics, Inc. Announced Results of Pre-Clinical Studies on Gene Expression at the American Association for Cancer Research 2008 Annual Meeting

  - 2008-04-16

  LOS ANGELES -- Response Genetics, Inc. (NASDAQ: RGDX), a company focused on the development of molecular diagnostic tests for cancer, presented several pre-clinical studies at the American Association for Cancer Research AACR 2008 Annual Meeting in San Diego, April 12-16. Kathleen Danenberg, CEO and President of Response Genetics, Inc., co-presented...

• Response Genetics, Inc. Appoints John Ferrara to Its Board of Directors

  - 2008-04-10

  LOS ANGELES -- Response Genetics, Inc. (NASDAQ: RGDX), a company focused on the development of molecular diagnostic tests for cancer, announced today that John C. Ferrara has joined its Board of Directors. Mr. Ferrara is currently the Chief Financial Officer CFO for EDGAR[R] Online[R], Inc. (NASDAQ: EDGR) a...

• Response Genetics Reports Full Year 2007 and Fourth Quarter Financial Results

  - 2008-03-26

  Conference Call Today at 5 p.m. ET LOS ANGELES -- Response Genetics, Inc. (NASDAQ: RGDX) a company focused on the development of molecular diagnostic tests for cancer, today announced its consolidated financial results for the twelve months ended December 31, 2007 and the fourth quarter of 2007. ...

• Response Genetics, Inc. Launches ResponseDX™ Tests to Select Institutions

  - 2008-03-05

  Appoints New Vice President, Sales and Marketing Annual Strategic Update Conference Call Scheduled LOS ANGELES -- Response Genetics, Inc. (NASDAQ: RGDX) announced today that its ResponseDX: Lung[TM] and ResponseDX: Colon[TM] tests are now available to select medical institutions and practice groups through its CLIA-registered laboratory. ResponseDX:...

• Response Genetics, Inc. Presents at ROTH 20th Annual OC Growth Stock Conference

  - 2008-02-19

  LOS ANGELES -- Response Genetics, Inc. (NASDAQ:RGDX) today announced its President and CEO, Kathleen Danenberg, will provide a business overview, including an update on its ResponseDX[TM] PCR-based genetic tests, at the ROTH 20th Annual OC Growth Stock Conference at the Ritz Carlton Laguna Niguel, in Dana Point, California February 18-21....

• Incorporated: 1999
• CEO: Ms. Kathleen Danenberg
• Employees: 37